课题基金 / 基金详情

Production of insulin secreting cells derived from induced pluripotent stem cells for the treatment of Type 1 diabetes mellitus by cellular replacement therapy.

Production of insulin secreting cells derived from induced pluripotent stem cells for the treatment of Type 1 diabetes mellitus by cellular replacement therapy.
生产源自诱导多能干细胞的胰岛素分泌细胞,用于通过细胞替代疗法治疗 1 型糖尿病。
批准号:
199307
负责人:
Glew Riley A
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-02-01 至 2011-02-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 1 diabetes mellitus is a widespread disease that could potentially be treated through regenerative medicine. A promising treatment strategy is to transplant replacement cells capable of insulin production and secretion. By replacing these cells it
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金